PATENT CLAIM ANALYSIS

Application Number: 16217527
Application Type: Utility
Filing Date: 2018-12
Publication Date: 2019-04
Patent Classification: ["514", "472000"]

Abstract:
Uses of acyl-homoserine lactone compounds are described. In particular, uses of acyl-homoserine lactone compounds as anti-thrombotic agents, to inhibit platelets from becoming hypersensitive, and/or to prevent thrombosis, are described.

Claim (Index 8):
The method of  claim 1 , wherein the acyl-homoserine lactone compound inhibits signaling activities in the platelets.

Metadata:
- Claim Count in Document: 18.0
- Percentile: 98.0
- Lexical Diversity: 1.45833
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15764684', '14778327', '12019593', '10861224', '12676287']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7652313200435699
- 35 USC 102 Novelty (BERT): 0.6561157607876154
- Combined Prediction Score: 0.7543197641179744
- Mean Citation Score: 327.74213999999995
- Max Citation Score: 638.7832
- Similarity Product: 606.9386473827362

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test